A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus

Summary:

Familial neurohypophyseal diabetes insipidus (FNDI) is an autosomally dominant inherited disorder with a typical onset at one to six years of age. The genetic locus of FNDI is the arginine vasopressin-neurophysin II (AVP-NPII) gene. The gene encoding the precursor hormone (prepro-AVP-neurophysin II) is located in the chromosomal region 20p13 and contains three exons. Mutations that cause FNDI have been found to occur within the signal peptide of the prepro-AVP-neurophysin II precursor, within the coding sequence for neurophysin II and the vasopressin-coding sequence. - A family (four members with FNDI, two without FNDI) in three consecutive generations was investigated. - Index case was a now 22-year old man with a history of severe polyuria (18 L/day) and polydipsia first recognized at about 4-5 months of age. - The arginine vasopressin-neurophysin II gene was investigated by direct sequencing of PCR products amplified from each exon. Subsequently, a restriction analysis was performed to verify the sequencing results. - The affected individuals were found to have a missense mutation in exon 2 at nucleotide position 1887 (G to C) of the AVP-NPII gene. Using both restriction enzyme digestion and sequence analysis, the mutation was found in all affected family members, but not in the unaffected members studied. This mutation (1887 G to C) represents a novel mutation of the AVP-NPII gene.

Key words:

Neurohypophyseal diabetes insipidus - arginine vasopressin neurophysin II gene point mutation

References

• 1 Bergeron C, Kovacs K, Ezrin C, Mizzen C. Hereditary diabetes insipidus: an immunhistochemical study of the hypothalamus and pituitary gland.  Acta Neuropathol. 81 245-248 1991; 
• 2 Braverman L E, Mancini J P, McGoldrich D M. Hereditary and idiopathic types of diabetes insipidus. A case report with autopsy findings.  Ann Intern Med. 63 503-508 1965; 
• 3 Calvo B, Bilbao J R, Urrutia I, Eizaguirre J, Gaztambide S, Castano L. Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus.  J Clin Endocrinol Metab. 83 995-997 1998; 
• 4 Fuji H, Iida S, Moriwaki K. Familial neurohypophyseal diabetes insipidus associated with a novel mutation in the vasopressin-neurophysin II gene.  Int J Mol Med. 5 229-234 2000; 
• 5 Gagliardi P C, Bernasconi S, Repaske D R. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding GLY²³ in Neurophysin II.  J Clin Endocrinol Metab. 82 3643-3646 1997; 
• 6 Green J R, Buchan G C, Alvord E C, Swanson A G. Hereditary and idiopathic types of diabetes insipidus.  Brain. 90 707-714 1967; 
• 7 Heppner C, Kotzka J, Bullmann C, Krone W, Müller-Wieland D. Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus.  J Clin Endocrinol Metab. 83 693-696 1998; 
• 8 Ito M, Mori Y, Osio Y, Saiato H. A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.  J Clin Invest. 87 725-728 1991; 
• 9 McLeod J, Kovacs L, Gaskill M, Rittig S, Bradley G, Robertson G. Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation.  J Clin Endocrinol Metab. 77 599A-599G 1993; 
• 10 Repaske D R, Phillips J A, Kirby L T, Tze W J, D'Ercole A J, Battey J. Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus.  J Clin Endocrinol Metab. 70 752-757 1990; 
• 11 Repaske D R, Summar M L, Krishnamani M R, Gultekin E K, Arriazu M C, Roubicek M E, Blanco M, Isaac G B, Phillips J A. Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus.  J Clin Endocrinol Metab. 81 2328-2334 1996; 
• 12 Repaske D R, Medlej R, Gültekin E K, Krishnamani M RS, Halaby G, Findling J W, Phillips J A. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-Val in the signal peptide of the arginine Vasopressin/Neurophysin II/Copeptin Precursor.  J Clin Endocrinol Metab. 82 51-56 1997; 
• 13 Rittig S, Robertson G L, Siggaard C, Kovács L, Gregersen N, Nyborg J, Pedersen E B. Identification of 13 new mutations in the Vasopressin-Neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.  Am J Hum Genet. 58 107-117 1996; 
• 14 Rutishauser J, Böni-Schnetzler M, Böni J, Wichmann W, Huisman T, Vallotton M B, Froesch E R. A novel point mutation in the translation initiation codon of the Pre-Pro-Vasopressin-Neurophysin II gene: Cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus.  J Clin Endocrinol Metab. 81 92-198 1996; 
• 15 Sausville E, Carney D, Battey J. The human vasopressin gene is linked to the oxytocin gene and is selectiveley expressed in a cultured lung cancer cell line.  J Biol Chem. 260 10236-10241 1985; 
• 16 Siggaard C, Rittig S, Corydon T J, Andreasen P H, Jensen T G, Andresen B S, Robertson G L, Gregersen N, Bolund L, Pedersen E B. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation.  J Clin Endocrinol Metab. 84 2933-2941 2000;